Wright Looks To New Management, Hip Resurfacing To Get Back On Track
This article was originally published in The Gray Sheet
Executive Summary
Wright Medical Group believes a change in its management and release of the Conserve Plus hip resurfacing system could reverse the firm's recent sales slide
You may also be interested in...
Wright Medical Sales Gain On Strength Of Biologic, Extremity Implants In Q1
Accelerating sales growth in Wright Medical's biologic implant franchise and a robust performance by the orthopedic firm's extremity products contributed to corporate revenue growth of 9% to $94.3 million in the first quarter, the firm reported April 30
Wright Medical Sales Gain On Strength Of Biologic, Extremity Implants In Q1
Accelerating sales growth in Wright Medical's biologic implant franchise and a robust performance by the orthopedic firm's extremity products contributed to corporate revenue growth of 9% to $94.3 million in the first quarter, the firm reported April 30
Orthopedics In Brief
New CEO for Wright: Gary Henley will take the helm from interim CEO Barry Bays at Wright Medical, effective April 4. Henley brings 24 years of experience in the orthopedic industry. He has been with Orthofix since 1997, spending the past four years as president of the Americas division, and also draws on nearly ten years of experience with Smith & Nephew. Bays has held the interim CEO position since Laurence Fairey resigned the post in October following disappointing third-quarter results (1"The Gray Sheet" Dec. 12, 2005, p. 13). Bays will resume his role as executive chairman, the firm says...